Novartis
A Principal Scientist at Novartis joins the xDC team to advance next-generation targeted therapeutic platforms, focusing on biologics and drug-conjugate infrastructure. The role involves designing and evaluating innovative vectorization strategies, optimizing payload approaches, and collaborating across cross-functional teams to drive research decisions. Candidates must possess strong scientific judgment and expertise in biologics or antibody-drug conjugates to lead experimental design and interpret complex data.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
24% above the average for this role
Director, XDC Technical Lead
WuXi Biologics
Director, XDC Technical Lead
WuXi Biologics
Associate Principal Scientist – Bioassay, Cell Based Sciences, AR&D
MSD
Group Leader - Antibody Screening and Pharmacology
Cancer Research UK Jersey
Associate Director – Oncology Targeted Delivery- Safety Science & Discovery
AstraZeneca
Scientist, Biologics Discovery
GondolaBio Service Co, Inc.